Does the addition of pindolol accelerate or enhance the response to selective serotonin reuptake inhibitor antidepressants?

Pharmacotherapy

Volumn 19, Issue 2, 1999, Pages 205-212

  Puzantian, Talia ^a   Kawase, Kristina ^b  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BUSPIRONE; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; PAROXETINE; PINDOLOL; PLACEBO; SEROTONIN 1A ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE;

ALOPECIA; CLINICAL TRIAL; DEPRESSION; DRUG MECHANISM; DRUG POTENTIATION; DRUG RESPONSE; EDEMA; GASTROINTESTINAL TOXICITY; HUMAN; REVIEW; VISUAL IMPAIRMENT; XEROSTOMIA;

ANTIDEPRESSIVE AGENTS; DRUG SYNERGISM; HUMANS; PILOT PROJECTS; PINDOLOL; RANDOMIZED CONTROLLED TRIALS; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0032963581     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.19.3.205.30921     Document Type: Review

References (12)

1. Laird LK, Benefield WH. Mood disorders. I. Major depressive disorders. In: Young LY, Koda-Kimble MA, eds. Applied therapeutics: the clinical use of drugs, 4th ed. Spokane, WA: Applied Therapeutics, 1995:76.1-28.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed, international version. Washington, DC: Author, 1995:328.
3. Blier P, Bergeron R. The use of pindolol to potentiate antidepressant medication. J Clin Psychiatry 1998;59(suppl 5):16-23.
4. Artigas F, Perez V, Alvarez E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 1994;51:248-51.
5. Blier P, Bergeron R. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol 1995;15:217-22.
6. Blier P, Bergeron R, de Montigny C. Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response. Neuropsychopharmacology 1997;16:333-8.
7. Bakish D, Hooper CL, Thornton MD, Wiens A, Miller CA, Thibaudeau CA. Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy. Int Clin Psychopharmacol 1997;12:91-7.
8. Perez V, Gilaberte I, Faries D, Alvarez E, Artigas F. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment. Lancet 1997;349:1594-7.
9. Maes M, Vandoolaeghe E, Desnyder R. Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression. J Affect Disord 1996;41:201-10.
10. Tome MB, Isaac MT, Harte R, Holland C. Paroxetine and pindolol: a randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency. Int Clin Psychopharmacol 1997;12:81-9.
11. Berman RM, Darnell AM, Miller HL, Anand A, Charney DS. Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial. Am J Psychiatry 1997;154:37-43.
12. Zanardi R, Artigas F, Franchini L, et al. How long should pindolol be associated with paroxetine to improve the antidepressant response? J Clin Psychopharmacol 1997;17: 446-50.